A phase 1, open-label, controlled clinical trial to evaluate pharmacokinetics after administration of Technosphere insulin inhalation powder alone and with salbutamol (albuterol) and/or after methacholine challenge testing in subjects with asthma versus matched healthy subjects without asthma

Trial Profile

A phase 1, open-label, controlled clinical trial to evaluate pharmacokinetics after administration of Technosphere insulin inhalation powder alone and with salbutamol (albuterol) and/or after methacholine challenge testing in subjects with asthma versus matched healthy subjects without asthma

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jun 2012

At a glance

  • Drugs Insulin; Salbutamol
  • Indications Diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors MannKind Corporation
  • Most Recent Events

    • 12 Jun 2012 Additional trial location (USA) identified as reported by ClinicalTrials.gov.
    • 12 Jun 2012 Actual patient number is 30 according to ClinicalTrials.gov.
    • 22 May 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top